Click for next page ( R6


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page R5
(=TENES Committee Staff Mandate of the Committee Process of the Committee Introduction f~ti~; ISSUR 1: Issue 2: Issue 3: Issue 4: References Data Needed for Better Problem Definition ~ 111 TV The Funding of Clinical Investigation in the United States 6 Recommendations.... e ~ ~ e ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ 7 Training of the Young Clinical Investigator ~ the United States..~. 9 Resc~Lndations 10 Resource Considerations and Necessary Organization and Structure of Clinical Investigation 11 Recol=endations 11 Outcome Assessment Research 15 Rscom=endations ~ . 16 17 20 Affix A: Publications Consulted 23 Affix B: Position Ears by remittee Mama 29 v

OCR for page R5
Issue 1: m e Funding of Clinical Investigation in the United States Ruth S. Hanft Gerald D. Laubach Mitchell T. RabRin Issue 2: Training and Support of the Young Clinical Investigator in the United States myomas c. R~rigan David G. Nathan ~r1 C. E - k Robert M. Rose Barry Sherman (Submitter by David Martin) Paul D. Stolley Samuel A. Wells, Jr. Issue 3: Organizational Structure of Clinical Investigation in the Future William N. Kelley Elaine L. Larson I~uis lasagna Issue 4: me Need for Clinical Investigators to be Concerned with the Issues of Outcome Assessment and Cost-Effectiveness Analysis John E. Wennberg V1 30 31 36 48 50 51 54 57 59 61 63 65 69 70 75 78 81 82